Story perspectives

ACC Links Inflammation to Heart Disease, Urges Action

10/2/2025

49 9

Summary

Story summary

The American College of Cardiology (ACC) issued a statement linking inflammation to cardiovascular disease (CVD).
It emphasizes high-sensitivity C-reactive protein (hsCRP) testing to assess CVD risk.
Lifestyle changes, including diet and exercise, are recommended to reduce inflammation. Colchicine and canakinumab show promise.
The report calls for more research on anti-inflammatory therapies and greater physician awareness of inflammation's role in CVD.

1 of 1

Story summary

The American College of Cardiology (ACC) issued a statement linking inflammation to cardiovascular disease (CVD).
It emphasizes high-sensitivity C-reactive protein (hsCRP) testing to assess CVD risk.
Lifestyle changes, including diet and exercise, are recommended to reduce inflammation. Colchicine and canakinumab show promise.
The report calls for more research on anti-inflammatory therapies and greater physician awareness of inflammation's role in CVD.